Jordan J. P. Warunek

Jordan J. P. Warunek

Auto-generated profile, based on publicly available information

Jordan J. P. Warunek

Thomas E. Starzl Transplantation Institute University of Pittsburgh School of Medicine Pittsburgh PA USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JWJordan J.P. Warunek
Jordan J.P. Warunek
LFLu Fan
Lu Fan
XZXue Zhang
Xue Zhang
SWSihua Wang
Sihua Wang
SSSteven M. Sanders
Steven M. Sanders
HTHētH R. Turnquist
HētH R. Turnquist
Chronic rejection (CR) after organ transplantation is alloimmune injury manifested by graft vascular remodeling and fibrosis that is resistant to immunosuppression. Single-cell RNA-Seq analysis of MHC class II–mismatched (MHCII-mismatched) heart transplants developing chronic rejection identified graft IL-33 as a stimulator of tissue repair pathways in infiltrating macrophages and Tregs. Using IL-33–deficient donor mice, we show that graft fibroblast–derived IL-33 potently induced amphiregulin (Areg) expression by recipient Tregs. The assessment of clinical samples also confirmed increased expression of Areg by intragraft Tregs also during rejection. Areg is an EGF secreted by multiple immune cells to shape immunomodulation and tissue repair. In particular, Areg is proposed to play a major role in Treg-mediated muscle, epithelium, and nerve repair. Assessment of recipient mice with Treg-specific deletion of Areg surprisingly uncovered that Treg secretion of Areg contributed to CR. Specifically, heart transplants from recipients with Areg-deficient Tregs showed less fibrosis, vasculopathy, and vessel-associated fibrotic niches populated by recipient T cells. Mechanistically, we show that Treg-secreted Areg functioned to increase fibroblast proliferation. In total, these studies identify how a dysregulated repair response involving interactions between IL-33 + fibroblasts in the allograft and recipient Tregs contributed to the progression of CR.

1 December 2021 in ImmunoHorizons
Verified
Journal Article
Open access
PDF file
JWJordan Warunek
Jordan Warunek
RJRichard M. Jin
Richard M. Jin
SBSarah J. Blair
Sarah J. Blair
MGMatthew Garis
Matthew Garis
BMBrandon Marzullo
Brandon Marzullo
EWElizabeth Wohlfert
Elizabeth Wohlfert
Toxoplasma gondii infection has proven to be an ideal model to understand the delicate balance between protective immunity and immune-mediated pathology during infection. Lethal infection causes a collapse of T regulatory cells (Tregs) mediated by the loss of IL-2 and conversion of Tregs to IFN-γ–producing cells. Importantly, these Tregs highly express the Th1 transcription factor Tbet. To determine the role of Tbet in Tregs, we infected Tbx21f/f-Foxp3YFPCre and control Foxp3YFPCre mice with the type II strain of T. gondii, ME49. The majority of Tbx21f/f-Foxp3YFPCre mice succumbed to a nonlethal dose. Notably, parasite burden was reduced in Tbx21f/f-Foxp3YFPCre compared with Foxp3YFPCre control mice. We found that Tbx21f/f-Foxp3YFPCre mice have significantly higher serum levels of proinflammatory cytokines IFN-γ and TNF-α, suggestive of a heightened immune response. To test if CD4+ T cells were driving immunopathology, we treated Tbx21f/f-Foxp3YFPCre mice with anti-CD4–depleting Abs and partially rescued these mice. Broad-spectrum antibiotic treatment also improved survival, demonstrating a role for commensal flora in immunopathology in Tbx21f/f-Foxp3YFPCre mice. RNA sequencing analysis reinforced that Tbet regulates several key cellular pathways, including leukocyte activation, regulation of lymphocyte activation, and cell cycle progression, that help to maintain fitness in Tregs during Th1 responses. Taken together, our data show an important role for Tbet in Tregs in preventing lethal immunopathology during T. gondii infection, further highlighting the protective role of Treg plasticity in controlling immune responses to infection and the microbiota.

27 January 2024 in npj Regenerative Medicine
Verified
Journal Article
Open access
PDF file
JBJ. G. Bartolacci
J. G. Bartolacci
MBM. N. Behun
M. N. Behun
JWJ. P. Warunek
J. P. Warunek
TLT. Li
T. Li
ASA. Sahu
A. Sahu
SBStephen Badylak
Stephen Badylak
Injuries to skeletal muscle are among the most common injuries in civilian and military populations, accounting for nearly 60% of extremity injuries. The standard of care for severe extremity injury has been focused upon limb salvage procedures and the utilization of tissue grafts or orthotics in conjunction with rehabilitation to avoid amputation. Nonetheless, many patients have persistent strength and functional deficits that permanently impact their quality of life. Preclinical and clinical studies have shown that partial restoration of functional skeletal muscle tissue following injury can be achieved by the implantation of a biologic scaffold composed of extracellular matrix (ECM). These favorable outcomes are mediated, at least in part, through local immunomodulation. The mechanisms underlying this immunomodulatory effect, however, are poorly understood. The present study investigates a potential mechanistic driver of the immunomodulatory effects; specifically, the effect of selected ECM components upon inflammation resolution and repair. Results show that the host response to skeletal muscle injury is profoundly altered and functional recovery decreased in il33−/− mice compared to age- and sex-matched wildtype counterparts by 14 days post-injury. Results also show that IL-33, contained within matrix-bound nanovesicles (MBV), supports skeletal muscle regeneration by regulating local macrophage activation toward a pro-remodeling phenotype via canonical and non-canonical pathways to improve functional recovery from injury compared to untreated il33−/− counterparts. Taken together, these data suggest that MBV and their associated IL-33 cargo represent a novel homeostatic signaling mechanism that contributes to skeletal muscle repair.

27 August 2025 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
MBMatthew A. Borrelli
Matthew A. Borrelli
JWJordan J. P. Warunek
Jordan J. P. Warunek
TRTarini Ravikumar
Tarini Ravikumar
SBStephen C. Balmert
Stephen C. Balmert
SLSteven R. Little
Steven R. Little
Poly(lactic-co-glycolic acid) terminated with charged terminal groups physical property assessment, quantification of formed microparticle degradation and uptake by phagocytes, and measurement of biomolecule release.

18 October 2026 in Advanced Healthcare Materials
Verified
Journal Article
Open access
MBMatthew A. Borrelli
Matthew A. Borrelli
ARAlexis T. Reese
Alexis T. Reese
JWJordan J. P. Warunek
Jordan J. P. Warunek
BVBetsy Ann Varghese
Betsy Ann Varghese
CLCanxing Lin
Canxing Lin
HTHēth R. Turnquist
Hēth R. Turnquist
Ischemic heart disease is a highly prevalent and debilitating condition throughout the world. Following an ischemic injury, the immune response can become overly active and spread damage to nearby healthy tissue. Because the heart lacks regenerative capacity, preventing excessive damage is critical. Existing immunosuppressive therapeutics provide indiscriminate suppression of inflammatory and repair functions of infiltrating immune cells. Regulatory T cells (Treg) are the body's highly sophisticated system for regulating immunologic activity. These cells can provide powerful immune suppression while amplifying repair pathways through direct stimulation of local cells. Our research group has previously developed a polymeric delivery system comprised of poly(lactic‐co‐glycolic acid) (PLGA) degradable microparticles (MP) loaded with the Treg‐attracting protein, CCL22. In our previous work, we demonstrated CCL22MP attracts Treg to the injection site and can suppress disadvantageous inflammation. Here we combine our Treg‐attracting MP technology with H ydrogels to E nhance or A ttract R egulatory T cells ( HEART ). Topically applied HEART significantly reduced infarct size and improved ejection fraction after permanent‐ligation MI, and in a cardiac transplant ischemia model reduced graft fibrosis while significantly increasing intragraft Foxp3 + Treg at 30 days. Efficacy tracked with injury severity, identifying severe ischemic injury as a setting where this therapeutic strategy may be most beneficial.

4 September 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
JWJordan Warunek
Jordan Warunek
RJRichard M. Jin
Richard M. Jin
SBSarah J. Blair
Sarah J. Blair
MGMatthew Garis
Matthew Garis
BMBrandon Marzullo
Brandon Marzullo
EWElizabeth Wohlfert
Elizabeth Wohlfert
T. gondii infection has proven to be an ideal model to understand the delicate balance between protective immunity and immune-mediated pathology during infection. Lethal infection causes a collapse of Tregs mediated by loss of IL-2, and conversion of Tregs to IFNγ producing cells. Importantly, these Tregs highly express the Th1 transcription factor Tbet. To determine the role of Tbet in Tregs, we infected Tbx21 f/f -Foxp3 YFPCre and control Foxp3 YFPCre mice with the type II strain of T. gondii , ME49. The majority of Tbx21 f/f -Foxp3 YFPCre mice succumb to a non-lethal acute infection. Notably, parasite burden is comparable between Tbx21 f/f -Foxp3 YFPCre and Foxp3 YFPCre control mice. We found that Tbx21 f/f -Foxp3 YFPCre mice have significantly higher serum levels of proinflammatory cytokines IFNγ and TNFα, suggestive of a heightened immune response. To test if CD4 + T cells were driving immunopathology, we treated Tbx21 f/f -Foxp3 YFPCre mice with anti-CD4 depleting antibody and partially rescued these mice. Broad spectrum antibiotic treatment also improved survival, demonstrating a role for commensal flora in immunopathology in Tbx21 f/f -Foxp3 YFPCre mice. RNA-seq analysis reinforced that Tbet regulates several key cellular pathways, including chromosome segregation, cytokine receptor activity and cell cycle progression, that help to maintain fitness in Tregs during Th1 responses. Taken together, our data shows an important role for Tbet in Tregs in preventing lethal immunopathology during Toxoplasma gondii infection, further highlighting the protective role of Treg plasticity to self and microbiota.